Kitakaze M, Hori M, Takashima S, Sato H, Inoue M, Kamada T
First Department of Medicine, Osaka University School of Medicine, Japan.
Circulation. 1993 Jan;87(1):208-15. doi: 10.1161/01.cir.87.1.208.
Adenosine has been reported to mediate the necrosis-limiting effects of ischemic preconditioning; however, it is unclear how this mediation occurs. The present study was undertaken to test the hypothesis that ischemic preconditioning increases 5'-nucleotidase activity and adenosine release during sustained ischemia and subsequent reperfusion.
After thoracotomy, the left anterior descending coronary artery was cannulated and perfused with blood redirected from the left carotid artery in 32 dogs. Ischemic preconditioning was produced by four cycles in which the coronary artery was occluded and then reperfused for 5 minutes each. After the last cycle of ischemia and reperfusion, the coronary artery was occluded for 40 minutes. This was followed by 120 minutes of reperfusion. In the control group, the coronary artery was occluded for 40 minutes and reperfused for 120 minutes without ischemic preconditioning. The plasma adenosine concentration was measured and blood gases were analyzed in coronary arterial and venous blood samples taken during 120 minutes of reperfusion. Myocardial 5'-nucleotidase activity was measured before and at 40 minutes of sustained ischemia with and without ischemic preconditioning. The adenosine concentration in coronary venous blood during reperfusion was significantly higher in preconditioned hearts than in the control hearts: 1 minute after the onset of reperfusion, 546 +/- 57 versus 244 +/- 41 pmol/ml; 10 minutes after, 308 +/- 30 versus 114 +/- 14 pmol/ml; 30 minutes after, 175 +/- 24 versus 82 +/- 16 pmol/ml, respectively (p < 0.01). Ectosolic and cytosolic 5'-nucleotidase activities increased in both endocardial and epicardial myocardium in the ischemia-preconditioned hearts. Furthermore, 40 minutes of ischemia increased 5'-nucleotidase activity in ischemia-preconditioned hearts more than in control hearts.
Ischemic preconditioning increases adenosine release and 5'-nucleotidase activity during sustained ischemia and subsequent reperfusion.
据报道,腺苷介导缺血预处理的坏死限制作用;然而,尚不清楚这种介导是如何发生的。本研究旨在验证以下假设:缺血预处理在持续缺血及随后的再灌注过程中会增加5'-核苷酸酶活性和腺苷释放。
开胸后,对32只犬的左冠状动脉前降支进行插管,并灌注来自左颈动脉的 redirected 血液。通过四个周期产生缺血预处理,每个周期冠状动脉闭塞然后再灌注5分钟。在最后一个缺血和再灌注周期后,冠状动脉闭塞40分钟。随后进行120分钟的再灌注。在对照组中,冠状动脉闭塞40分钟并再灌注120分钟,未进行缺血预处理。在再灌注的120分钟内采集冠状动脉动脉和静脉血样本,测量血浆腺苷浓度并分析血气。在有和没有缺血预处理的情况下,在持续缺血40分钟之前和之时测量心肌5'-核苷酸酶活性。预处理心脏再灌注期间冠状动脉静脉血中的腺苷浓度显著高于对照心脏:再灌注开始后1分钟,分别为546±57与244±41 pmol/ml;10分钟后,308±30与114±14 pmol/ml;30分钟后,175±24与82±16 pmol/ml,(p<0.01)。缺血预处理心脏的心内膜和心外膜心肌中的胞外和胞质5'-核苷酸酶活性均增加。此外,40分钟的缺血使缺血预处理心脏中的5'-核苷酸酶活性比对照心脏增加更多。
缺血预处理在持续缺血及随后的再灌注过程中增加腺苷释放和5'-核苷酸酶活性。